Brave girl of 13 beats leukaemia in world-first clinical trial 

A 13-year-old girl has been cleared of her terminal cancer after a world-first trial involving a revolutionary type of medicine.

Alyssa had undergone chemotherapy and a bone marrow transplant – but her leukaemia remained.

The teenager from Leicester then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street Hospital for Children in London.

Doctors said that without the treatment her next step would have been palliative care, but within a month, Alyssa went into remission.

Brave girl of 13 beats leukaemia in world-first clinical trial 

Alyssa, 13, had undergone chemotherapy and a bone marrow transplant – but her leukaemia remained

The teenager from Leicester then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street Hospital for Children in London

The teenager from Leicester then received genetically-edited T-cells in the first use of the therapy at Great Ormond Street Hospital for Children in London

Speaking before the experimental treatment, Alyssa said: ‘Once I do it, people will know what they need to do, one way or another, so doing this will help people – of course I’m going to do it.’

The pre-manufactured cells, from a healthy volunteer donor, were edited using new technology to allow them to hunt down and kill cancerous T-cells without attacking each other. T-cells are white blood cells which move around the body to find and destroy defective cells.

Alyssa was diagnosed with T-cell acute lymphoblastic leukaemia (T-ALL) last year. It is the most common cancer in children and young people, affecting 500 each year, and the survival rate for those whose T-ALL has relapsed is just 10 per cent.

Alyssa was the first patient in the T-cell clinical trial, which was funded by the Medical Research Council.

Before receiving the treatment, Alyssa said: ‘Once I do it, people will know what they need to do, one way or another, so doing this will help people – of course I’m going to do it'

Before receiving the treatment, Alyssa said: ‘Once I do it, people will know what they need to do, one way or another, so doing this will help people – of course I’m going to do it’

Twenty-eight days after being given the treatment, Alyssa was in remission, and was able to have a second bone marrow transplant. She is said to be ‘doing well at home’ and continues with follow-up monitoring at Great Ormond Street. Scientists working on the clinical trial hope to recruit up to ten T-ALL patients who have exhausted all conventional options.

Professor Waseem Qasim, consultant immunologist at GOSH, said: ‘This is a great demonstration of how, with expert teams and infrastructure, we can link cutting-edge technologies in the lab with real results in the hospital for patients. It’s our most sophisticated cell engineering so far and paves the way for other new treatments and ultimately better futures for sick children.’

Alyssa’s mother Kiona said the family were ‘on a strange cloud nine’.

She added: ‘Hopefully this can prove the research works and they can offer it to more children – all of this needs to have been for something.’

Rishi hails Mail campaign to tackle children’s cancer

By Kate Pickles and Jason Groves for The Daily Mail

Rishi Sunak today declares that he is ‘proud’ to support the Daily Mail’s children’s cancer campaign.

Praising this paper’s partnership with Cancer Research UK, the Prime Minister said more needed to be done to beat childhood cancer and gave his full backing to the ‘excellent’ cause.

The Mail has teamed up with Cancer Research UK to launch the Fighting to Beat Children’s Cancer campaign, which is raising money for research into children and young people’s cancers.

Prime Minister Rishi Sunak (pictured) said more needed to be done to beat childhood cancer and gave his full backing to the ‘excellent’ cause

Prime Minister Rishi Sunak (pictured) said more needed to be done to beat childhood cancer and gave his full backing to the ‘excellent’ cause

The Government announced last month that it was committing £22.5million to develop new therapies, including targeted vaccines, as well as finding methods of earlier diagnosis.

Mr Sunak said: ‘I’m proud to support the excellent Fighting to Beat Children’s Cancer campaign led by the Daily Mail and Cancer Research UK.

‘The NHS is diagnosing many more patients with cancer at an earlier stage than before but we need to do more to improve treatment and outcomes, particularly amongst children.

‘That is why we’re investing tens of millions of pounds in life-saving cancer research and opening over 100 community diagnostic centres across the country, delivering two million tests, scans and checks locally.’

Mr Sunak added: ‘Together we can beat cancer and the Fighting to Beat Children’s Cancer campaign is a hugely welcome contribution to that effort.’

The Government wants to follow the success of strategies that were used to secure and roll out the Covid vaccine.

The funding will form part of the NHS Cancer Programme, which aims to spot three quarters of cancers at stage one or two by 2028.

The programme also aims to help 55,000 more people each year to survive for at least five years after diagnosis.

Cancer remains the leading cause of death by disease in youngsters in the UK, killing one in five of those diagnosed – around 500 a year.

Cancer Research UK estimates that cases will rise by a fifth by 2040.

All money raised will support the charity’s work on cancers affecting young people, so that more 0-24 year olds can survive with a good quality of life.

For all the latest health News Click Here 

Read original article here

Denial of responsibility! TechAI is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.